Skip to main content
Caplight Logo









Restore Vision Inc.

Restore Vision Inc.

Private
TokyoHealthcare & Life Scienceshttps://restore-vis.com/

Last Round

Series A

Dec 15, 2023

Total Funding Raised

$25.23M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Restore Vision Inc. is a Japanese biopharmaceutical company that develops gene therapies for patients with retinal disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyoptogeneticsretinal disordersretinitis pigmentosaadeno-associated virusAAVregenerative medicineblindness treatmentbiotech startupclinical-stage biotechvision restorationeye gene therapyintravitreal injectioninherited blindnessbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Restore Vision Inc. Comparables

Compare Restore Vision Inc. with similar companies based on industry and business-model similarity.

Restore Vision Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanoscope Therapeutics Inc.
86%
Ray Therapeutics
81%
Bionic Sight, Inc.
80%

Restore Vision Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 15, 2023
Series AJun 5, 2023
SeedFeb 4, 2022

Key People

Founding team and executive leadership

Yusaku Katada

CEO

Executive Team

Hikaru Miyazaki

Representative Director and COO

Executive Team

Restore Vision Inc. Investors

Notable investors and investment history

Restore Vision Inc. investors
InvestorRounds
Higin CapitalSeries A
Remiges VenturesSeries A, Seed
ANRI株式会社Series A, Seed
QB CapitalSeries A
Spiral CapitalSeries A
Kyoto University Innovation CapitalSeries A
Japan Science and Technology AgencySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    Grew 43% QoQ from 7 to 10 employees.

  • Dec 15, 2023

    $13M round led by Remiges Ventures.

Restore Vision Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Restore Vision Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Restore Vision Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range8
Year Founded2016
Last FundingDec 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?